Total Pageviews

Showing posts with label Vocabria. Show all posts
Showing posts with label Vocabria. Show all posts

Monday, July 14, 2025

More Long Options


Viiv is promoting findings for their long acting PrEP & HIV meds.  They promote data that supports the efficacy of & preference for their long acting meds; Apretude, Vocabria & Cabenuva.  These injections aren't as long acting as Gilead's Lenacapavir.  There may be other reasons to prefer Viiv's options.

The company has also pledged to let some low income countries manufacture & market generic versions of these meds.  Making these drugs far more affordable.  This & Gilead's similar pledge were most likely due to public pressure & the US ceasing funding to HIV programs.

That's all for now, take care.

Cya...

Friday, January 22, 2021

FDA Approved...

 

I blogged the European Union approved a long acting injectable med for HIV  based on cabotegravir & rilpivirine.  The injection, Cabenuva is given monthly.   An oral regimen will proceed it for a month & is marketed as, Vocabria.  ViiV Healthcare is researching how to extend the time between injections.  The FDA recently approved this med.

 Taken from the piece.

The most common adverse reactions ... were injection site reactions, fever (pyrexia), fatigue, headache, musculoskeletal pain, nausea, sleep disorders, dizziness and rash. 

I'll try to keep up with this.  Take care

Cya...

Monday, January 4, 2021

Long Acting Approved...

 

The European Union has given medical authorization to it's 1st long acting HIV treatment.  According to this piece, Vocabria, also know as Cabotegravir from ViiV healthcare  & Janssen  Pharmaceutical, has been given clearance to move ahead with once monthly injections.

The treatment starts in a traditional manner with daily tablets for a month, to determine tolerance to the meds.  After, the dosage would switch to once monthly injections.  The company is in the process of developing an injection that would be taken every 2 months.   I'd assume the process would be the same; tablets, single month injection & the longer lasting dose.

This could change the HIV game.  It could mean oral meds are heading out of the top tier position.  Patients would have to see a medical professional for the injections.  There'd be more contact with those needing medical care.

That's all for now, take care.

Cya...